...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Expands Phase 2b Clinical Trial for COVID-19

paladin -The good news is that there doesn't currently seem to be any reason to stop the trial but rather continue to expand it to reach the 100 patient goal. 

Could be wrong, the P2b on C19 time was 28 days for each patient?  No news, patient still lives.  Seems we are getting close to 28.  Hoping the patient is home and getting better.  Imagine the news release, "First ABL patient cured of C19, shows no signs of Long Covid in blood".  "Returned to normal activity sooner than expected."

Should an open study have an announcement?  Any one know?  sidebar.

Share
New Message
Please login to post a reply